需求幾十篇文獻(xiàn) 1.Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer 2、J Clin Gastroenterol. 2016 Jan;50(1):e1-7. Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. Tan VP1, Wong BC, Wong WM, Leung WK, Tong D, Yuen MF, Fass R. 3、Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Gut. 2018 Mar;67(3):430-440. 4、The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. Chen TS, Chang FY. J Clin Gastroenterol. 2007 Oct;41(9):819-22. 5、 Circulation. 1998 Nov 24;98(21):2282-9. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Senni M1, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. 6、 Anesth Analg. 2018 Nov 9. doi: 10.1213/ANE.0000000000003887. [Epub ahead of print] Side Effect Rates of Opioids in Equianalgesic Doses Via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis. 7. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD 8.Macromolecules, 1983, 16 (8), pp 1367-1374DOI: 10.1021/ma00242a019 Publication Date: August 1983 ACS Legacy Archive 9、Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats Kai Zhang Zuowang Ma Weiding Wang Ruimeng Liu Yue Zhang Meng Yuan Guangping Li 10、Vascular. 2018 Dec;26(6):626-633. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia. 嚴(yán)重肢體缺血患者潰瘍愈合和無(wú)截肢生存的預(yù)后因素 Furuyama T, Onohara T, Yamashita S, Yoshiga R, Yoshiya K, Inoue K, Morisaki K, Kyuragi R, Matsumoto T, Maehara Y. 11、Curr Drug Discov Technol. 2018 Oct 8. Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review.   [更多]

需要BP2017 KetoconazoleCream質(zhì)量標(biāo)準(zhǔn)的PDF版本   [更多]

求購(gòu)“Tolbutamide”《 BP2017 》的藥典標(biāo)準(zhǔn)一份.   [更多]

求助左氧氟沙星及片標(biāo)準(zhǔn)一份.《 USP42-NF37 》   [更多]

標(biāo)題：重金求購(gòu)伐地那非BP2017標(biāo)準(zhǔn)一份 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]

求購(gòu)“Chondroitin Sulfate Sodium”《 USP42-NF37 》的藥典標(biāo)準(zhǔn)一份.   [更多]

標(biāo)題：求購(gòu)鹽酸托烷司瓊質(zhì)量標(biāo)準(zhǔn) 詳細(xì)要求：鹽酸托烷司瓊EP9.4的、BP2018的質(zhì)量標(biāo)準(zhǔn)各一份 要求時(shí)間：2018年10月18日之前 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]

歐洲/歐盟藥典9.0版。請(qǐng)高人相助，謝謝！   [更多]

求拉莫三嗪原料藥及片劑，英國(guó)藥典最新標(biāo)準(zhǔn)（最好有2018版）   [更多]

求《1,4-二[N-（2-（3-吡啶酰胺基）亞乙基）]氨基-5,8-二羥基蒽醌的合成與結(jié)構(gòu)表征》文獻(xiàn)。電子版，掃描或者PDF都可以。   [更多]